Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients

CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5 days. Repli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Sung, Cynthia, Wei, Yuan, Watanabe, Satoru, Lee, How Sung, Khoo, Yok Moi, Fan, Lu, Rathore, Abhay P. S., Chan, Kitti Wing-Ki, Choy, Milly M., Kamaraj, Uma S., Sessions, October M., Aw, Pauline, de Sessions, Paola F., Lee, Bernett, Connolly, John E., Hibberd, Martin L., Vijaykrishna, Dhanasekaran, Wijaya, Limin, Ooi, Eng Eong, Low, Jenny Guek-Hong, Vasudevan, Subhash G.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980036/
https://ncbi.nlm.nih.gov/pubmed/27509020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados